|
|
Persistent Cutaneous Hyperpigmentation After Tyrosine Kinase Inhibition With Imatinib for GIST
|
| Link ID |
9046 |
| Title |
Persistent Cutaneous Hyperpigmentation After Tyrosine Kinase Inhibition With Imatinib for GIST |
| Url |
http://www.medscape.com/viewarticle/579403?src=rss |
| Description |
Imatinib mesylate, a tyrosine kinase inhibitor, is an important part of the therapeutic armamentarium used in chronic myelogenous leukemia and gastrointestinal stromal tumors. Dermatological toxicities occur with the clinical use of this drug range from various acute rashes to Steven-Johnson syndrome. Hyperpigmentation of the skin is a less frequent side effect.
Dermatology Online Journal |
| Category |
Articles > Dermatology |
| Keywords |
|
| Date |
Sep 26, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Dermatology |
|
|
